Silence Therapeutics (SLN) Accumulated Depreciation & Amortization (2023 - 2024)
Historic Accumulated Depreciation & Amortization for Silence Therapeutics (SLN) over the last 2 years, with Q4 2024 value amounting to $4.5 million.
- Silence Therapeutics' Accumulated Depreciation & Amortization rose 810.38% to $4.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.5 million, marking a year-over-year increase of 810.38%. This contributed to the annual value of $4.5 million for FY2024, which is 60.03% up from last year.
- Latest data reveals that Silence Therapeutics reported Accumulated Depreciation & Amortization of $4.5 million as of Q4 2024, which was up 810.38% from $4.2 million recorded in Q4 2023.
- In the past 5 years, Silence Therapeutics' Accumulated Depreciation & Amortization ranged from a high of $4.5 million in Q4 2024 and a low of $4.2 million during Q4 2023